Home | Welcome to Contract Pharma   
Last Updated Saturday, May 25 2013
Print

Industry News

Related Searches:

Filter by:

January 14, 2011
ICON has acquired Oxford Outcomes, an international health outcomes consultancy, expanding its late phase and outcomes research services.   Read More »
January 14, 2011
ShangPharma Corp. began operations on the initial phase of production at its new pharmaceutical development and cGMP manufacturing facility in Fengxian, China.   Read More »
January 13, 2011
CRI Worldwide has completed its acquisition of Lifetree Clinical Research.   Read More »
January 13, 2011
RecipharmCobra Biologics, in collaboration with the Royal Holloway, University of London and the Universita Cattolica del Sacro Cuore of Rome, Italy, has released the results of a study to develop an oral vaccine against tuberculosis.   Read More »
January 12, 2011
Intertek, a provider of quality and safety solutions for a wide range of industries around the world, has acquired American Analytical Chemistry Laboratories Corp.   Read More »
January 12, 2011
An affiliate of Sun European Partners, LLP has entered into an agreement to acquire NextPharma Technologies Holding Ltd., a global provider of contract manufacturing, product development, clinical trials and logistics services to the pharmaceutical and bi   Read More »
January 12, 2011
Xcellerex, Inc. has received the Invensys Operations Management OPEN award for “innovative use of Invensys products and solutions to generate considerable business results” in four Operational Excellence categories.   Read More »
January 11, 2011
Elite Pharmaceuticals, Inc. and Hi-Tech Pharmacal Co., Inc. have entered into an agreement under which Elite will develop an intermediate for Hi-Tech for a generic version of a prescription product.   Read More »
January 11, 2011
PPD, Inc. has established a joint venture with Taijitu Biologics Ltd. (TBL), named BioDuro Biologics, to discover novel biotherapeutics.   Read More »
January 11, 2011
DSM BioSolutions, Royal DSM's microbial fermentation contract manufacturing business, and BiAqua B.V., a bio-based solutions provider for serious water contamination issues, have entered into an agreement for strain development, process development and pr   Read More »
January 10, 2011
AMT has entered into an agreement with Institut Pasteur, and a group of French research institutes (the "Consortium"), to support clinical development of a gene therapy to treat Sanfilippo B.   Read More »
January 7, 2011
Savient Pharmaceuticals provided an update on its business activities related to the U.S. launch and commercialization of Krystexxa, a PEGylated uric acid specific enzyme for the treatment of chronic gout.   Read More »
January 7, 2011
Cambrex Zenara is supplying product for Johnson & Johnson Ltd.'s launch of smoking cessation drug Nicorette in India.   Read More »
January 6, 2011
AMRI has merged its Discovery R&D and Discovery Chemistry departments to form a Global Drug Discovery organization.   Read More »
January 4, 2011
XOMA Ltd. and Les Laboratoires Servier have signed an agreement to jointly develop and commercialize XOMA 052 in multiple indications.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On